Long-term health benefit of ibalizumab in the treatment of adults with multidrug-resistant HIV-1 infection

Brogan, A. J., Talbird, S. E., Davis, A. E., La, E. M., Miao, Z., & Lewis, S. (2018). Long-term health benefit of ibalizumab in the treatment of adults with multidrug-resistant HIV-1 infection. Value in Health, 21, S12. https://doi.org/10.1016/j.jval.2018.04.062